A Study of Rocbrutinib Combined With R-GemOx in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to DLBCL
Related studies linked through entity extraction aliases.
Gut Microbiome in DLBCL Treated With Glofitamab
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
A Real-world Data and Sample Compendium of Frail and/or Multiply Treated Large B-cell Lymphoma
- Status
- RECRUITING
- Phase
- N/A
Multicenter, Single-Arm Exploratory Phase I Clinical Study (Assessment of Safety and Efficacy) of Fully Human BAFF-R Chimeric Antigen Receptor T-Cell Injection in Relapsed/Refractory BAFF-R-Positive B-Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Safety and Efficacy of Anti-EBV Autologous TCR-T Cell Injection in Relapsed/Refractory EBV-Positive Lymphoma
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Study on Predicting Response to Standard First-Line Treatment in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Using ctDNA Combined With PET
- Status
- RECRUITING
- Phase
- N/A
Cardiotoxicity and Other Late Effects After Radiotherapy and Immuno-chemoTherapy in Non-Hodgkin lYmphoma
- Status
- COMPLETED
- Phase
- N/A
A Multicenter, Prospective, Real-world Study of a Regimen Containing Tucidinostat for Primary Treatment of DLBCL
- Status
- RECRUITING
- Phase
- N/A
Clinical Study of HiR+X Therapy for Newly Diagnosed Elderly Patients with DLBCL Intolerant to Chemotherapy
- Status
- RECRUITING
- Phase
- PHASE2
CD-RCHOP in ND DLBCL With a Combination of TP53 Mutation and Del(17p)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
CR-CHOP+X in Previously Untreated DEL
- Status
- RECRUITING
- Phase
- PHASE2
Zanubrutinib Combined With BEAM for ASCT in Relapsed and Refractory DLBCL
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of Trilaciclib Combined With Chemotherapy in the Treatment of Diffuse Large B-Cell Lymphoma Patients
- Status
- RECRUITING
- Phase
- PHASE2
SynKIR-310 for Relapsed/Refractory B-NHL
- Status
- RECRUITING
- Phase
- PHASE1
Evaluate the Safety and Efficacy of Tafasitamab and Lenalidomide in Combination With Gemcitabine and Oxaliplatin Versus Rituximab in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE3
Dose Dense Chemotherapy in Elderly Patients > 80 Years Old With DLBCL
- Status
- COMPLETED
- Phase
- N/A
P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Real-world Study of Selinexor-based Regimens for Treatment of Non-Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- N/A
ACE1831 in Adult Subjects With Relapsed/ Refractory CD20-expressing B-cell Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Evaluate the Safety and Efficacy of Tafasitamab Combined With Lenalidomide in Patients With Relapsed or Refractory DLBCL
- Status
- RECRUITING
- Phase
- PHASE2